Amid covid surge, Iran cut corners to approve yet-unproven vaccine (Washington Post)

August 26, 2022
Amid covid surge, Iran cut corners to approve yet-unproven vaccine

As Iranian regulators considered endorsing a locally developed coronavirus vaccine a year ago, a top health official issued a stern warning, saying the test results were insufficient and the vaccine’s approval could undermine efforts to contain the country’s raging epidemic.

Deputy Health Minister Farid Najafi wrote to his boss that allowing use of the vaccine by the general public before it met scientific standards “is a serious and historic decision that will determine the future of public confidence in the health system.”

But the vaccine had influential backers. It was the highly touted project of a company called Barkat, part of a sprawling corporate empire close to Iran’s supreme leader, Ayatollah Ali Khamenei.

...

In March of the following year, Mokhber said the company was now prepared to mass-produce the vaccine. “We promise to the beloved Iranian nation that in 2½ months, we won’t have to worry about vaccine shortage in this country,” he said.

Iranian officials portrayed this endeavor as a point of national pride that would catapult Iran into an elite group of scientifically advanced countries. After the government’s troubled response in the early days of the pandemic, much of the Iranian media devoted wide and favorable coverage to Barkat’s project.

“There’s a desire to record a win for the supreme leader,” said Amir Afkhami, a professor and expert on Iranian public health at George Washington University. “On top of that, there’s a financial gain and the financial power and the revenue stream that Setad provides for Khamenei.”

Read the full article on WashingtonPost.com

Latest News

September 15, 2022
Stork bites and angel’s kiss sound poetic, but they actually describe vascular birthmarks, skin changes that commonly appear at or shortly after birth. These marks may change over time, so it’s important to get a dermatologist’s opinion from day one.
September 15, 2022
The GW Medical Faculty Associates (GW MFA) is pleased to welcome Meghan M. Smith, MBA, as the Executive Director of Practice Operations in the Department of Medicine. In this role, Smith will work with executive, clinical, and physician leadership to develop and implement strategies, manage key…
September 15, 2022
The GW Medical Faculty Associates (GW MFA) welcomes Hitan Kamdar, MBA, MS, as executive director of patient access. Kamdar will be responsible for optimizing patient access to ambulatory care at the GW MFA. In this role, he will oversee call operations, the Unified Contact Center, provider capacity…